XENTRIOR

Swiss trademark · 555716 · Word mark · In force

Register entry

Registration number
555716
Application number
61413/2006
Status
In force
Type
Word mark
Filed
Dec 15, 2006
Registered
Feb 20, 2007
Published
Mar 6, 2007
Protected until
Dec 15, 2026
Priority
06.07.2006 US
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate zur Behandlung von Krebs.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 14, 2023

    Agent’s address changed

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 14.12.2023

  2. Sep 14, 2016

    Address changed

    Owner
    Agouron Pharmaceuticals, Inc., 10777 Science Center Drive, CA 92121 San Diego, USA → Agouron Pharmaceuticals, LLC, 10646 Science Center Drive, San Diego, CA 92121, USA

    Published in Swissreg on 14.09.2016

  3. Sep 14, 2016

    Renewed

    Published in Swissreg on 14.09.2016

  4. Mar 6, 2007

    Registered

    Published in the SOGC no. 45 of 06.03.2007

Parties

Holder

Agouron Pharmaceuticals, LLC

10646 Science Center Drive, San Diego, CA 92121, US

Agent

E. Blum & Co. AG

Hofwiesenstrasse 349, 8050 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.